Table 4.
Outcomes in patients with early esophageal adenocarcinoma limited to stage T0 and T1a by treatment
| Variable | Endoscopic eradication therapies (n=281) | Esophagectomy (n=756) | P-value |
|---|---|---|---|
|
| |||
| Patients with 2-year follow-up (n,%)1 | 199 (70.8) | 621 (82.1) | <0.001 |
| 2-year survival | 158 (79.4) | 531 (85.5) | 0.041 |
| 2-year EC related mortality | 16 (8.0) | 56 (9.0) | 0.672 |
| 2-year other cause mortality | 25 (12.6) | 34 (5.5) | 0.001 |
| Patients with 5-year follow-up (n,%)2 | 91 (32.4) | 294 (38.9) | 0.054 |
| 5-year survival | 13 (14.3) | 128 (43.5) | <0.001 |
| 5-year EC related mortality | 29 (31.9) | 99 (33.7) | 0.749 |
| 5-year other cause mortality | 49 (53.9) | 67 (22.8) | <0.001 |
1
271 patients censored (20.9% with <2 yrs. follow-up)
2
652 patients censored (62.9% with <5 yrs. follow-up)